Hospital Universitari Mutua Terrassa — Clinical Trial Site

21 Registered trials

6 Currently recruiting

Organisation

Hospital Universitari Mutua Terrassa

Location

Terrassa, Spain

Identifier

ORL-000000956

Address

Plaza del Dr. Robert 5, 08221, Spain

Departments

Hematología
Hematology
Hematology Unit
infectious diseases
Intensive Care Department
Medical Oncology
N/A
NA
Neurología
ONCOLOGIA
Oncology
Oral and maxillofacial surgery
Reumatología
Servicio de Enfermedades Infecciosas
UCG Enfermedades Infecciosas, Microbiología y Medicina preventiva

Clinical trials at this site (21)

Search interface

A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy with Standard-of-Care Combination Regimens … Pending

2024-519504-27-00 Relapsed Refractory Multiple Myeloma 5
Staphylococcus aureus Network Adaptive Platform trial (SNAP) Pending

2025-521388-11-00 Staphylococcus aureus bacteraemia 4
A phase 2b, randomized, double-blind study of redasemtide (S-005151) in adult participants with acute ischemic stroke Recruiting

2022-501890-38-00 acute ischemic stroke 4 2024-02-16
A Randomized, Open-labelled, Multicenter Trial Evaluating Efficacy and Safety of A Reduced Venetoclax Exposure To Seven Days Versus Standard… Recruiting

2025-521634-29-00 Acute Myeloid Leukemia 5 2026-03-02
Ampicillin and ceftriaxone for the treatment of Enterococcus faecalis infective endocarditis. Recruiting

2024-511719-40-00 Enterococcus faecalis infectious endocarditis 6 2024-10-09
C1071032 - MAGNETISMM-32 A PHASE 3, OPEN-LABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMB, POMALIDOMIDE, DEXAMETHASONE (EPd) OR POMAL… Recruiting

2023-507871-23-00 Relapsed/Refractory Multiple Myeloma 5 2024-05-27
A Trial to Learn if Odronextamab Combined with Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined … Recruiting

2022-502113-28-00 Follicular lymphoma 5 2024-02-01
MagnetisMM-6: A Phase 3 Study of Elranatamab (PF-06863135) + Daratumumab + Lenalidomide Versus Daratumumab + Bortezomib + Lenalidomide + Dex… Recruiting

2024-514139-50-00 Multiple myeloma 5 2022-11-14
Effect of Tranexamic Acid Oral Solution 5% in patients treated with direct oral anticoagulants or vitamin K antagonists and undergoing a sin… Ended

2023-503719-13-00 Prevention of clinically relevant bleeding events in pa 5 2024-05-06
Clinical trial to evaluate the safety and efficacy of a 7-day versus 14-day treatment for enterococcal infections. Ended

2023-508456-18-00 Uncomplicated bacteremia caused by E. faecalis or E. fa 6 2024-04-29
Study with Various Immunotherapy Treatments in Participants With Lung Cancer Ended

2022-502916-35-01 Advanced Non-Small Cell Lung Cancer 4 2024-03-27
A Study to Learn How Linvoseltamab (REGN5458) Will Work Compared to the Elotuzumab, Pomalidimide and Dexamethasone (EPd) Combination, in Par… Ended

2022-501396-62-00 Relapsed Refractory Multiple Myeloma 5 2023-12-12
Extended VRD plus Early Rescue vs Isatuximab-VRD vs Isatuximab-VIberdomide-D for NDMM patients who are candidates for ASCT Ended

2024-517008-12-00 Newly-diagnosed multiple myeloma (NDMM) 5 2022-10-14
MagnetisMM-5: A Phase 3 Study of Elranatamab (PF-06863135) Monotherapy and Elranatamab + Daratumumab Versus Daratumumab + Pomalidomide + Dex… Ended

2023-509208-14-00 MULTIPLE MYELOMA 5 2021-09-28
Treatment for previously untreated patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) with an IDH1 or IDH2 mutatio… Ended

2022-502832-37-00 Acute myeloid leukemia 5 2019-03-01
A large-scale comparative study evaluating an intravenous treatment, cabazitaxel, and radiation therapy to the pelvic lymph nodes in patient… Ended

2024-517622-25-00 Patients with localized prostate cancer and high-risk f 5 2013-12-06
A multicentre clinical trial to assess the safety and tolerability of the combination of low-dose cytarabine or azacitidine, plus Venetoclax… Ended

2024-519275-26-00 Newly diagnosed acute myeloid leukemia patients aged eq 9 2024-11-15
Temocilin vs meropenem for the treatment of infections due to Enterobacteriales Ended

2023-508440-21-00 Infections due to Enterobacteriaceae 5 2024-05-21
A Multicenter, Randomized, Double-Blind, Comparative, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous Imipenem/Cilastatin-X… Ended

2022-501952-27-00 Hospital-acquired bacterial pneumonia (HABP), including 5 2024-04-19
Study Drug vs Placebo as an “add on” treatment for Severe Community-Acquired Pneumonia. Ended

2023-505985-28-01 Severe Community-Acquired Pneumonia 4 2024-03-04
A randomized, multi-centre, double-blind, phase II clinical trial of dose finding of Montelukast in patients with erosive osteoarthritis of … Ended

2023-506137-30-00 Erosive osteoarthritis of the hands 4 2024-01-11